MEDIFAST (MED)
(Delayed Data from NYSE)
$18.68 USD
-0.31 (-1.63%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $18.69 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Cash flow Statements
Fiscal Year End for MEDIFAST INC falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 99.42 | 143.57 | 164.03 | 102.86 | 77.92 |
Depreciation/Amortization & Depletion | 12.94 | 10.99 | 6.90 | 7.59 | 5.08 |
Net Change from Assets/Liabilities | 20.28 | 21.65 | -87.65 | 26.58 | -8.51 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 15.03 | 18.36 | 11.26 | 8.17 | 9.77 |
Net Cash From Operating Activities | 147.66 | 194.57 | 94.55 | 145.20 | 84.26 |
Property & Equipment | -6.48 | -16.68 | -34.21 | -5.89 | -10.06 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -54.56 | 5.27 | 5.15 | 4.61 | 3.73 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -61.05 | -11.41 | -29.06 | -1.28 | -6.33 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -6.77 | -127.96 | -61.28 | -3.95 | -46.93 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -73.02 | -71.62 | -63.86 | -53.19 | -35.40 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | -79.79 | -199.58 | -125.13 | -57.14 | -82.32 |
Effect of Exchange Rate Changes | -0.07 | -0.07 | 0.11 | -0.02 | 0.00 |
Net Change In Cash & Equivalents | 6.75 | -16.49 | -59.54 | 86.75 | -4.39 |
Cash at Beginning of Period | 87.69 | 104.18 | 163.72 | 76.97 | 81.36 |
Cash at End of Period | 94.44 | 87.69 | 104.18 | 163.72 | 76.97 |
Diluted Net EPS | 9.10 | 12.73 | 13.89 | 8.68 | 6.43 |
Fiscal Year End for MEDIFAST INC falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 0.16 | 8.32 | 99.42 | 93.38 | 70.25 |
Depreciation/Amortization & Depletion | 5.96 | 3.07 | 12.94 | 9.75 | 6.34 |
Net Change from Assets/Liabilities | -6.05 | -5.06 | 20.28 | 29.55 | 23.56 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 20.28 | 0.96 | 15.03 | 4.45 | 7.05 |
Net Cash From Operating Activities | 20.35 | 7.28 | 147.66 | 137.14 | 107.21 |
Property & Equipment | -3.78 | -1.84 | -6.48 | -5.54 | -3.86 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -1.53 | -0.93 | -54.56 | -44.78 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -5.31 | -2.78 | -61.05 | -50.32 | -3.86 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -0.80 | -0.78 | -6.77 | -6.85 | -6.74 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -0.71 | -0.71 | -73.02 | -55.04 | -37.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | -1.51 | -1.49 | -79.79 | -61.88 | -43.73 |
Effect of Exchange Rate Changes | 0.04 | 0.02 | -0.07 | 0.13 | 0.10 |
Net Change In Cash & Equivalents | 13.58 | 3.03 | 6.75 | 25.06 | 59.71 |
Cash at Beginning of Period | 94.44 | 94.44 | 87.69 | 87.69 | 87.69 |
Cash at End of Period | 108.02 | 97.47 | 94.44 | 112.75 | 147.41 |
Diluted Net EPS | -0.75 | 0.76 | 0.54 | 2.12 | 2.77 |